EP Patent

EP3181549A1 — Process for the preparation of apremilast

Assigned to Zaklady Farmaceutyczne Polpharma SA · Expires 2017-06-21 · 9y expired

What this patent protects

This invention provides a process for preparing apremilast, comprising reacting compounds of formula I and formula II or a salt thereof where neither acetic nor formic acid are present.

USPTO Abstract

This invention provides a process for preparing apremilast, comprising reacting compounds of formula I and formula II or a salt thereof where neither acetic nor formic acid are present.

Drugs covered by this patent

Patent Metadata

Patent number
EP3181549A1
Jurisdiction
EP
Classification
—
Expires
2017-06-21
Drug substance claim
No
Drug product claim
No
Assignee
Zaklady Farmaceutyczne Polpharma SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.